Skip to content

IMMUNOMEDICS, INC.

CIK 0000722830

← back to feed
Revenue (TTM)
$20.07M
Q2 Jul 2020
Net Income (TTM)
−$329.76M
−5.6% YoY Q2 Jul 2020
EPS Diluted (TTM)
−$0.17
−366.7% YoY Q2 Jul 2020
Gross Margin
3.6%
Q2 Jul 2020
Operating Margin
-1,439.3%
Q2 Jul 2020
Net Margin
-1,642.7%
Q2 Jul 2020
Free Cash Flow (TTM)
−$217.04M
Q2 Jul 2020
Cash
$971.19M
Q2 Jul 2020
Total Debt
—
Q2 Jul 2020
Shares Outstanding
231.14M sh
Q2 Jul 2020

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings